VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ASH 2022 | What to look forward to at ASH 2022 in the field of Waldenström’s macroglobulinemia

In this video, Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, highlights what he is looking forward to at the 2022 ASH Annual Meeting, including updates on next-generation Bruton’s tyrosine kinase (BTK) inhibitors, and the importance of biomarkers in Waldenström’s macroglobulinemia (WM). This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter